Piper Sandler Raises AbbVie (ABBV) Price Target to $349
Bullish analyst signal based on a raised target with material implied upside.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst signal based on a raised target with material implied upside.
What happened, with direct paths to the underlying reporting
Piper Sandler raised its price target to $349 from an unspecified prior target; the posted price was $289.20. The target implies roughly 21% upside, though analyst targets are opinions.
Target: $349
Posted price: $289.2
Analyst firm: Piper Sandler
Analyst: David Amsellem
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.